Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Bioventus Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 53 | 69 | +16 |
| Shares | 20.7M | 24.8M | +4.13M (+19.9%) |
| Value | $364.5M | $351.8M | −$12.7M (−3.5%) |
New holders (23)
Institutions that held Bioventus Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (7)
Institutions that held Bioventus Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 778,567 | $13.7M |
| Prospector Partners LLC | 124,355 | $2.19M |
| Acadian Asset Management LLC | 12,461 | $220.0K |
| Ameriprise Financial Inc | 12,096 | $110.0K |
| C M Bidwell & Associates Ltd | 2,525 | $44.0K |
| UBS Group AG | 1,753 | $31.0K |
| Advisory Services Network, LLC | 106 | $2.00K |